MS vs SPRB · P/E 20, $344.27B cap vs rev $4.9M
Morgan Stanley (MS) versus Spruce Biosciences Inc (SPRB) — a side-by-side from cached financials, not a winner call.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Spruce Biosciences Inc (SPRB) is a biotechnology company listed on US.
MS does not have a complete income-statement cache yet.
Latest reported SPRB revenue for 2024-12-31 was $4.9M. Net income was -$53.0M. Revenue was down 51.3% from 2023-12-31 to 2024-12-31. SPRB currently screens at market cap $3.0M.
MS currently screens at market cap $344.27B and trailing P/E 19.8. SPRB currently screens at market cap $3.0M.
Not investment advice. Open the MS and SPRB stock pages for the full models.
Not investment advice.